Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on August 13, 2021. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Metabolomics Evaluation of the Age-Related Eye Disease Study 2 (AREDS2)

Closed
75N98021P02397Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541715
New
Federal
Nassau Proposers Day
Solicitation # DARPA-SN-27-08
The Defense Advanced Research Projects Agency's Information Processing Techniques Office is hosting a Proposers Day for the anticipated Nassau program, a critical infrastructure resilience initiative. This event, identified by special notice DARPA-SN-27-08, is designed to provide potential proposers with technical goals and challenges associated with the program. The Nassau program is divided into two technical areas: Technical Area 1 focuses on modeling a specific class of critical infrastructure, while Technical Area 2 contains restricted information available only via a classified SECRET addendum. This notice is for informational and planning purposes and does not constitute a formal solicitation for proposals. Interested organizations must meet stringent security and cybersecurity standards to access program addendums. For the Controlled Unclassified Information addendum, organizations must provide a Supplier Performance Risk System affirmation of CMMC level 2 compliance and adhere to NIST SP 800-171, DoDI 8582.01, and DFARS 252.204-7021 safeguarding requirements. Those seeking the classified addendum must possess a valid SECRET or higher Facility Clearance Letter from the Defense Counterintelligence and Security Agency and have access to SAV, JWICS, or DSWAN networks. Requests for the CUI addendum must be submitted by November 2, 2026, with the anticipated release of addendums occurring on December 10, 2026.
Defense Advanced Research Projects Agcy

POSTED

about 22 hours ago

DEADLINE

in 17 days
NAICS: 541715
New
Federal
ARMY APPLICATIONS LABORATORY BROAD AGENCY ANNOUNCEMENT FOR DISRUPTIVE TECHNOLOGIES
Solicitation # W911NF-24-S-0008
The United States Army Futures Command, through the Army Applications Lab, has issued Broad Agency Announcement W911NF-24-S-0008 to solicit disruptive technology applications. This initiative aims to modernize the Army by leveraging civilian research, development, and innovation ecosystems to create a first-mover advantage. The program focuses on seven key priorities: Long-Range Precision Fires, Next Generation Combat Vehicles, Future Vertical Lift Platforms, the Army Network, Air and Missile Defense Capabilities, Soldier Lethality, and Contested Logistics. The effort is structured around three main lines of action: the discovery of novel capability concepts, the acceleration of technology demonstrators that provide a significant improvement over current capabilities, and the translation of these innovations into scalable Army advantages. The Army is specifically seeking advancements in Fourth Industrial Revolution technologies, including artificial intelligence, robotics, autonomy, quantum information systems, synthetic biology, and advanced power and energy systems. There is a strong emphasis on translational research and the development of dual-use solutions that serve both military needs and commercial markets. This solicitation, managed by the Army Contracting Command in Research Triangle Park, North Carolina, remains active from April 5, 2024, through April 5, 2029, with performance centered in Austin, Texas.
W6QK Acc-Apg Durham

POSTED

about 22 hours ago

DEADLINE

in over 2 years
NAICS: 541715
New
Federal
Call 03 M-DASH - Joint All Domain Persistent Adaptive Collaborative Technologies II (JADPACT II)
Solicitation # FA238426SB007
The Joint All Domain Persistent Adaptive Collaborative Technologies II (JADPACT II) project, specifically the Multi-Decision Advantage Sprint for Human-Machine Teaming (M-DASH), is a research effort led by the Air Force Research Laboratory. The program aims to develop Human-Machine Teaming concepts and AI/automation capabilities to provide Battle Managers with decision advantage within the Combined Joint All-Domain Command and Control (CJADC2) framework. The effort focuses on the Transformational Model for Decision Advantage (TM-DA) to bridge the gap between operational concepts and software design, specifically requiring solutions that address three decision services: PAE, MEF, and GBC. The M-DASH event is a two-week simulation sprint scheduled for January 25 to February 5, 2027, in Las Vegas, Nevada. The government anticipates awarding Firm Fixed Price contracts or Other Transaction agreements with a maximum value of 100,000 dollars per selected offeror, out of a total estimated program cost of 600,000 dollars. Payment is issued as a single sum upon the conclusion of the event and the successful delivery of a Technical Review Presentation Package, which must include an end-of-event presentation, a technology survey, and simulated run digital audit logs. Eligibility for award requires offerors to have a CMMC Level 1 Self assessment and undergo a rigorous Science and Technology Protection risk review for all senior and key personnel. Proposals were due by October 21, 2026, and were subject to strict page limits for both the proposal and the Statement of Work. All deliverables must be submitted electronically to a government-controlled repository, and contractors must comply with AFRL supplemental requirements regarding patent rights, CUI marking, and security risk disclosures.
FA2384 USAF Afmc Afrl Pzl Afrl Rakh

POSTED

about 22 hours ago

DEADLINE

in about 11 hours
NAICS: 541715
New
Federal
U.S. Army Contracting Command – Watervliet Arsenal (ACC-WVA) Organic Industrial Base (OIB) Modernization Commercial Solutions Opening (CSO)
Solicitation # W911PT26SC001
The U.S. Army Contracting Command – Watervliet Arsenal (ACC-WVA) has issued solicitation W911PT26SC001, a Commercial Solutions Opening (CSO) authorized under the National Defense Authorization Act for Fiscal Year 2026 and DFARS Subpart 212.70. This competitive solicitation is open until September 30, 2027, and is designed to acquire innovative commercial products, technologies, and services to modernize the Army's Organic Industrial Base. The scope focuses on integrating manufacturing resources, linking legacy analogue systems with digital systems, and expanding modeling and simulation to enhance the delivery of materiel solutions. The CSO targets both traditional and non-traditional business entities, including small businesses and foreign-owned firms, provided they maintain an active System for Award Management (SAM) profile and a Unique Entity ID. The acquisition process follows a multi-phased approach consisting of a written solution brief, an optional presentation or pitch, and a final Request for Commercial Solution Proposal (CSP). Evaluation is based on responsiveness, technical merit, uniqueness, and price reasonableness. Successful responses may result in fixed-price contracts awarded under FAR Part 12 Commercial Item Procedures. Current Areas of Interest (AoIs) include advanced cannon technology, electrical infrastructure improvements at Building 120, chromium facility conversion, automated manufacturing for minor components, automated cooling tower treatments, advanced CNC vertical turning lathes, and advanced tooling for radial forging. Performance is primarily located at Watervliet Arsenal and Benet Laboratories, with a general period of performance not to exceed 12 months unless otherwise specified.
W6QK Acc Wva

POSTED

about 22 hours ago

DEADLINE

in 11 months
NAICS: 541715
New
Federal
ITS4US Deployment Accelerator
Solicitation # 693JJ3-27-BAA-0001
The ITS4US Deployment Accelerator, solicitation 693JJ3-27-BAA-0001, is a Broad Agency Announcement issued by the Department of Transportation's Intelligent Transportation Systems Joint Program Office. The program aims to award up to five operational pilots to integrate and deploy mobility technology solutions designed to improve healthcare accessibility. Awardees will utilize open-source software and documentation from the ITS4US Deployment Program, specifically focusing on integrating transportation scheduling into healthcare booking systems, deploying trip planning applications, and enhancing Health Connector middleware. The total estimated acquisition value is 1,625,000 dollars, with each of the five potential awards valued at 325,000 dollars over an 18-month period of performance. Proposals are due by January 11, 2027, and must be submitted in two volumes: a technical proposal limited to 15 pages and a price proposal. Evaluation is conducted under FAR Part 35 for Research and Development Contracting, focusing on technical merit, agency program importance, and fund availability, with cost considered in the final award decision. Key requirements include the appointment of a Deployment Lead, Systems Engineering Lead, and Project Management Lead, as well as strict adherence to Section 508 accessibility standards. All software developed with federal funding must be shared as open-source resources via the USDOT ITS CodeHub. Work is to be performed at the contractor's facilities, and payments may be structured via a Milestone Payment Schedule.
693JJ3 Acquisition And Grants Mgt

POSTED

about 22 hours ago

DEADLINE

in 3 months

General Info

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

Morrisville, NC, 27560, USA

Set-Aside

NONE

Documents

2

JOFOC+-+SAM+-+Exec.pdf

PDF

STATEMENT-OF-WORK-AREDS2+-+SAM.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed
Posted

special-notice

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Office AddressBETHESDA, MD, 20892, USA
Contacts

Full Description

Show more
The National Institutes of Health, Office of Logistics and Acquisition Operations (OLAO), Office of Acquisitions (OA), on behalf of the National Eye Institute (NEI) intends to solicit a fixed price contract via FAR 13.5 with Metabolon, Inc., to perform a non-targeted metabolomics evaluation of participants aged 55 and older who were enrolled in the randomized controlled clinical trial Age-Related Eye Disease Study 2 (AREDS2 [2006 to 2012]) with varying severity of age-related macular degeneration (AMD) at baseline and followed longitudinally. Approximately 2,001 samples will be evaluated. The anticipated period of performance is 12 months from date of award. NAICS: 541715, Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) Authority: FAR 13.5. Simplified Procedures for Certain Commercial Items. This Notice is not a request for proposals, proposal abstracts, or quotations and does not commit the Government to any contractual agreement. All responsible sources may submit a capability statement, proposal, or quotation which shall be considered by the agency.

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

NAICS: 325411
New
Federal
NOI - B2B Award entitled - Developing Red Cell-Sp
Solicitation # 75N98027Q00017
Solicitation 75N98027Q00017 is a combined synopsis and notice of intent for a non-competitive award by the National Institutes of Health (NIH) to Purdue University, specifically the Purdue Institute for Drug Discovery. The contract supports the Bench-to-Bedside study Developing Red Cell-Specific Spleen Tyrosine Kinase (SYK) Inhibitors for Treating Sickle Cell Disease. The scope of work for the Year 1 requirement involves the synthesis, scale-up, characterization, and optimization of lead SYK inhibitors S1115 and S1213, with a delivery requirement of approximately 3 to 5 grams of each compound along with supporting analytical and potency data. The award is justified as non-competitive because Purdue University possesses the project-specific knowledge and prior research experience necessary to avoid technical risk and duplication of effort. The acquisition is conducted under FAR 12.603 for commercial items and is not expected to exceed the simplified acquisition threshold. Research activities will be performed at Purdue University in West Lafayette, Indiana, with deliverables sent to the National Heart, Lung, and Blood Institute in Bethesda, Maryland. The associated NAICS code is 325411 for Medicinal and Botanical Manufacturing, and the requirement is not set aside for small businesses. Administrative requirements include active registration in the System for Award Management and the use of the Invoicing Processing Platform for three-way match payments. Responses were due by November 4, 2026, to the contracting specialist, Nicholas Capobianco.
Medicinal and Botanical Manufacturing

POSTED

about 22 hours ago

DEADLINE

in 14 days
View Details
NAICS: 541614
New
Federal
R--RADx Coordination Center Notice of Intent
Solicitation # 75N98026R00176
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) has issued a Notice of Intent under solicitation 75N98026R00176 to award a non-competitive modification to IDIQ Contract No. 75N92022D00014. This modification intends to increase the contract ceiling for the Massachusetts General Hospital Consortia for Improving Medicine with Innovation and Technology (CIMIT) to support the Rapid Acceleration of Diagnostics (RADx-Tech) initiative. The initiative operates as an innovation funnel to accelerate the development, commercialization, and implementation of health technologies through a collaborative network consisting of a Coordination Center for operational oversight and workflows, a Commercialization Center for subject matter expert selection, and a Validation Center for technical and clinical verification. The government anticipates issuing the modification around December 2026. While this is a non-competitive intent, interested parties may submit capability statements via email to the contracting officer, Melanie Suarez, or contract specialist, Noelle Decenzo, by November 2, 2026. Submissions must reference the notice number and include details regarding employee count, professional qualifications of technical personnel, available facilities and equipment, and an outline of similar previous research projects. All responding parties must maintain an active registration in the System for Award Management (SAM).
Process, Physical Distribution, and Logistics Consulting Services

POSTED

5 days ago

DEADLINE

in 12 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS